The sublingual version means that you put the medicine under your tongue, allowing it to absorb directly into your bloodstream
The 2026 Coverage Reality Check What Insurance Covers Weight Loss Medication: The 2026 Coverage Reality Tool: cost calculator Sources FDA, Zepbound (tirzepatide) prescribing information, OSA label expansion, December 2024 Malhotra A et al
Compounded Tirzepatide (Injectable) has not been evaluated by the FDA, but side effects are expected to be similar to other Tirzepatide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Compounding pharmacies will sometimes repackage these drugs, or create lower or different concentrations than whats typically available